BCL2 and chronic myelogenous leukemia, BCR-ABL1 positive: One example is the switch in BCL2 family member isoform expression from the pro-apoptotic to pro-survival isoforms that contributes to apoptosis resistance of the LSC and has been described and both observed in both MDS and CML disease progression.